Drug Absorption Studies: In Situ, In Vitro and In Silico Models 

<br/><br/><br/>English[eng] 
<br/><br/><label>ISBN: </label>9783040000000 
<br/><br/><label>Subjects--Topical Terms: </label><br/>rebamipide||nanocrystals||oral mucositis||hydrogel||endocytosis||enoxaparin||lipid–polymer hybrid nanoparticles||oral||intestinal absorption||naftidrofuryl oxalate||solubility||permeability||dissolution profiles||pharmaceutical availability||BCS drug classification||non-sink condition||solubility–permeability interplay||unstirred water layer||poorly soluble drugs||solubilizer additive||phenylketonuria||l-phenylalanine ammonia-lyase||enzyme||kinetics||catabolism disorder||biomedical drug||P-glycoprotein||breast cancer resistance protein||LY335979||WK-X-34||in vivo–in vitro correlation||lipolysis-permeation||lipid-based drug delivery system||PermeaPad||cinnarizine||lipolysis||amorphous solid dispersion||candesartan Cilexetil||PVPK30||pH-modulation||spray drying||bioavailability||nasal administration||spray-drying||chitosan||microsphere||meloxicam||silymarin||D-α-Tocopherol polyethylene glycol 1000 succinate (TPGS)||liver distribution||acetaminophen-induced hepatotoxicity||extra virgin olive oil||secoiridoids||metabolism||phenolic compounds||intestinal permeability||drug-phytochemical interaction||hepatic metabolism||mixed inhibition||quercetin||repaglinide